Effect of Dexamethason on Postimplantation Syndrome After EVAR
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 158 participants.
Also called NCT06044480
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 158 participants
- Sponsor
- Centro Hospitalar de Lisboa Central
- Registry
-
NCT06044480
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06044480. Randomized; triple masking; primary purpose prevention. Start 2023-11-01 (anticipated); primary completion 2025-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Dexamethason on Postimplantation Syndrome After EVAR
- Acronym
- DEPOS
- Condition
- Aneurysm Abdominal
- Condition
- Endovascular Aneurysm Repair
- Condition
- Postimplantation Syndrome
- Condition
- Dexamethasone
- Intervention (Drug)
- Dexamethasone
- Intervention (Other)
- Placebo
- Lead sponsor
- Centro Hospitalar de Lisboa Central
Record details
- Record id
cardio:ct-nct06044480- Content hash
65edc69eebea976b21e4a0c3c48827a3fd1df47037c61aa10d44ad85afabccfa